139 related articles for article (PubMed ID: 17193686)
1. Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent.
Shiftan L; Neeman M
Contrast Media Mol Imaging; 2006; 1(3):106-12. PubMed ID: 17193686
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma.
Shiftan L; Israely T; Cohen M; Frydman V; Dafni H; Stern R; Neeman M
Cancer Res; 2005 Nov; 65(22):10316-23. PubMed ID: 16288020
[TBL] [Abstract][Full Text] [Related]
3. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
4. Labeling fibroblasts with biotin-BSA-GdDTPA-FAM for tracking of tumor-associated stroma by fluorescence and MR imaging.
Granot D; Kunz-Schughart LA; Neeman M
Magn Reson Med; 2005 Oct; 54(4):789-97. PubMed ID: 16149062
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors.
Hassid Y; Furman-Haran E; Margalit R; Eilam R; Degani H
Cancer Res; 2006 Apr; 66(8):4159-66. PubMed ID: 16618737
[TBL] [Abstract][Full Text] [Related]
6. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.
Hiltunen EL; Anttila M; Kultti A; Ropponen K; Penttinen J; Yliskoski M; Kuronen AT; Juhola M; Tammi R; Tammi M; Kosma VM
Cancer Res; 2002 Nov; 62(22):6410-3. PubMed ID: 12438225
[TBL] [Abstract][Full Text] [Related]
7. Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI.
Xin X; Sha H; Shen J; Zhang B; Zhu B; Liu B
Oncol Rep; 2016 Jun; 35(6):3227-35. PubMed ID: 27035336
[TBL] [Abstract][Full Text] [Related]
8. Parametric imaging of tumor perfusion using flow- and permeability-limited tracers.
Bogin L; Margalit R; Mispelter J; Degani H
J Magn Reson Imaging; 2002 Sep; 16(3):289-99. PubMed ID: 12205585
[TBL] [Abstract][Full Text] [Related]
9. Reaction-complexation coupling between an enzyme and its polyelectrolytic substrate: determination of the dissociation constant of the hyaluronidase-hyaluronan complex from the hyaluronidase substrate-dependence.
Lenormand H; Amar-Bacoup F; Vincent JC
Biophys Chem; 2013; 175-176():63-70. PubMed ID: 23523464
[TBL] [Abstract][Full Text] [Related]
10. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Lokeshwar VB; Young MJ; Goudarzi G; Iida N; Yudin AI; Cherr GN; Selzer MG
Cancer Res; 1999 Sep; 59(17):4464-70. PubMed ID: 10485499
[TBL] [Abstract][Full Text] [Related]
11. Development of a fluorescent substrate to measure hyaluronidase activity.
Zhang LS; Mummert ME
Anal Biochem; 2008 Aug; 379(1):80-5. PubMed ID: 18492482
[TBL] [Abstract][Full Text] [Related]
12. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
13. NMRD investigation of DyDTPA- and GdDTPA-labeled starch particles. Selection of a suitable suspension medium and influence of the starch matrix on relaxivity.
Fossheim SL; Spiller M; Kellar KE
Invest Radiol; 1999 Apr; 34(4):287-95. PubMed ID: 10196721
[TBL] [Abstract][Full Text] [Related]
14. Rapid MR imaging of renal perfusion: a comparative study of GdDTPA, albumin-(GdDTPA), and magnetite.
Daly PF; Zimmerman JB; Gillen JS; Wolf GL
Am J Physiol Imaging; 1989; 4(4):165-74. PubMed ID: 2696525
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.
Hompland T; Gulliksrud K; Ellingsen C; Rofstad EK
Acta Oncol; 2013 Apr; 52(3):627-35. PubMed ID: 23126523
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.
de Lussanet QG; Langereis S; Beets-Tan RG; van Genderen MH; Griffioen AW; van Engelshoven JM; Backes WH
Radiology; 2005 Apr; 235(1):65-72. PubMed ID: 15731376
[TBL] [Abstract][Full Text] [Related]
17. The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI.
Zhang W; Chen Y; Guo DJ; Huang ZW; Cai L; He L
Eur J Radiol; 2011 Sep; 79(3):369-74. PubMed ID: 21106316
[TBL] [Abstract][Full Text] [Related]
18. Phosphonate-modified GdDTPA complexes. II. Evaluation in a rat myocardial infarct model.
Adzamli IK; Johnson D; Blau M
Invest Radiol; 1991 Feb; 26(2):143-8. PubMed ID: 2055714
[TBL] [Abstract][Full Text] [Related]
19. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
[TBL] [Abstract][Full Text] [Related]
20. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
